KMT2A and acute leukemia: Pinometostat (Epizyme (EPZ)-5676), a DOT1L inhibitor, was one of the first histone methyltransferase inhibitors to undergo Phase I trials for both children and adults with r/r KMT2A-rearranged acute leukemia.